US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 37.360
  • -2.360-5.94%
Close Mar 31 16:00 ET
  • 37.860
  • +0.500+1.34%
Pre 04:07 ET
2.22BMarket Cap-11.32P/E (TTM)

About Apogee Therapeutics Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Company Profile

SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees196
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Websitehttp://www.apogeetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Henderson, M.D.
  • Chief Executive Officer and Director
  • 1.17M
  • Dr. Carl Dambkowski, M.D.
  • Chief Medical Officer
  • 870.83K
  • Jane Pritchett Henderson
  • Chief Financial Officer and Chief Accounting Officer
  • 1.72M
  • Mark C. McKenna
  • Chairman of the Board
  • 972.87K
  • Dr. Lisa L. Bollinger, M.D.
  • Director
  • --
  • Jennifer A. Fox
  • Independent Director
  • 414.57K
  • William B.J. Jones, Jr
  • Independent Director
  • 411.66K
  • Tomas Kiselak
  • Independent Director
  • 662.82K
  • Peter Harwin
  • Independent Director
  • 668.57K
  • Nimish Shah
  • Independent Director
  • 664.82K
  • Dr. Andrew Gottesdiener, M.D.
  • Independent Director
  • 666.57K

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025
Earnings Season Underway
Earnings season is here. What to know?